25 XP   0   0   10

Biotest Aktiengesellschaft
Buy, Hold or Sell?

Let's analyse Biotest Aktiengesellschaft together

PenkeI guess you are interested in Biotest Aktiengesellschaft. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Biotest Aktiengesellschaft. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Biotest Aktiengesellschaft

I send you an email if I find something interesting about Biotest Aktiengesellschaft.

Quick analysis of Biotest Aktiengesellschaft (30 sec.)










What can you expect buying and holding a share of Biotest Aktiengesellschaft? (30 sec.)

How much money do you get?

How much money do you get?
€0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
€9.44
Expected worth in 1 year
€9.81
How sure are you?
20.0%

+ What do you gain per year?

Total Gains per Share
€0.37
Return On Investment
0.9%

For what price can you sell your share?

Current Price per Share
€42.20
Expected price per share
€41.20 - €42.20
How sure are you?
50%
3rd Party Ad. No recommendation by Penke. PLUS is ad-free.

1. Valuation of Biotest Aktiengesellschaft (5 min.)




Live pricePrice per Share (EOD)

€42.20

Intrinsic Value Per Share

€-37.66 - €-44.83

Total Value Per Share

€-28.22 - €-35.39

2. Growth of Biotest Aktiengesellschaft (5 min.)




Is Biotest Aktiengesellschaft growing?

Current yearPrevious yearGrowGrow %
How rich?$410.6m$419.5m-$23.8m-6.0%

How much money is Biotest Aktiengesellschaft making?

Current yearPrevious yearGrowGrow %
Making money-$2.7m-$17.8m$15.1m551.0%
Net Profit Margin-3.8%-12.1%--

How much money comes from the company's main activities?

3. Financial Health of Biotest Aktiengesellschaft (5 min.)




4. Comparing to competitors in the Other industry (5 min.)




  Industry Rankings (Other)  


Richest
#119 / 408

Most Revenue
#198 / 408

Most Profit
#353 / 408

Most Efficient
#334 / 408
3rd Party Ad. No recommendation by Penke. PLUS is ad-free.

What can you expect buying and holding a share of Biotest Aktiengesellschaft? (5 min.)

Welcome investor! Biotest Aktiengesellschaft's management wants to use your money to grow the business. In return you get a share of Biotest Aktiengesellschaft.

What can you expect buying and holding a share of Biotest Aktiengesellschaft?

First you should know what it really means to hold a share of Biotest Aktiengesellschaft. And how you can make/lose money.

Speculation

The Price per Share of Biotest Aktiengesellschaft is €42.20. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Biotest Aktiengesellschaft.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Biotest Aktiengesellschaft, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is €9.44. Based on the TTM, the Book Value Change Per Share is €0.09 per quarter. Based on the YOY, the Book Value Change Per Share is €-0.40 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is €0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Biotest Aktiengesellschaft.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 % of Price per Share% of Price per Share% of Price per Share% of Price per Share% of Price per Share
Usd Eps0.621.5%-0.07-0.2%-0.45-1.1%-0.20-0.5%-0.15-0.4%
Usd Book Value Change Per Share0.621.5%0.100.2%-0.44-1.0%0.691.6%0.691.6%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share0.621.5%0.100.2%-0.44-1.0%0.691.6%0.691.6%
Usd Price Per Share45.74-45.79-46.53-35.53-34.08-
Price to Earnings Ratio18.54-34.09--41.54-23.34-18.26-
Price-to-Total Gains Ratio73.49--14.39--158.26--115.41--115.41-
Price to Book Ratio4.41-4.58-4.40-2.87-2.25-
Price-to-Total Gains Ratio73.49--14.39--158.26--115.41--115.41-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share46.39468
Number of shares21
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share0.100.69
Usd Total Gains Per Share0.100.69
Gains per Quarter (21 shares)2.1614.53
Gains per Year (21 shares)8.6358.11
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
109-105848
201780116106
3026170174164
4035260232222
5043350291280
6052440349338
7060530407396
8069620465454
9078710523512
10086800581570

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share2.02.00.050.0%3.09.00.025.0%3.012.00.020.0%3.012.00.020.0%3.012.00.020.0%
Book Value Change Per Share2.02.00.050.0%2.010.00.016.7%3.012.00.020.0%3.012.00.020.0%3.012.00.020.0%
Dividend per Share0.00.04.00.0%0.00.012.00.0%0.00.015.00.0%0.00.015.00.0%0.00.015.00.0%
Total Gains per Share2.02.00.050.0%2.010.00.016.7%3.012.00.020.0%3.012.00.020.0%3.012.00.020.0%
3rd Party Ad. No recommendation by Penke. PLUS is ad-free.

Fundamentals of Biotest Aktiengesellschaft

About Biotest Aktiengesellschaft

  • Other
  • 0

There is no Profile data available for BIO.DU.

Fundamental data was last updated by Penke on 2023-11-08 14:23:03.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is just able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is able to pay all its debts by selling its assets.
The company is just not able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is fair priced.
Based on the earnings, the company is overpriced.
Based on how much money comes from the company's main activities, the company is expensive.
3rd Party Ad. No recommendation by Penke. PLUS is ad-free.

1.1. Profitability of Biotest Aktiengesellschaft.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Biotest Aktiengesellschaft earns for each €1 of revenue.

  • Above 10% is considered healthy but always compare Biotest Aktiengesellschaft to the Other industry mean.
  • A Net Profit Margin of 14.1% means that €0.14 for each €1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Biotest Aktiengesellschaft:

  • The MRQ is 14.1%. The company is making a huge profit. +2
  • The TTM is -3.8%. The company is making a loss. -1
Trends
Current periodCompared to+/- 
MRQ14.1%TTM-3.8%+17.8%
TTM-3.8%YOY-12.1%+8.3%
TTM-3.8%5Y-6.2%+2.5%
5Y-6.2%10Y266.6%-272.8%
Compared to industry (Other)
PeriodCompanyIndustry (mean)+/- 
MRQ14.1%5.9%+8.2%
TTM-3.8%5.6%-9.4%
YOY-12.1%7.5%-19.6%
5Y-6.2%6.2%-12.4%
10Y266.6%6.0%+260.6%
1.1.2. Return on Assets

Shows how efficient Biotest Aktiengesellschaft is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Biotest Aktiengesellschaft to the Other industry mean.
  • 1.8% Return on Assets means that Biotest Aktiengesellschaft generated €0.02 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Biotest Aktiengesellschaft:

  • The MRQ is 1.8%. Using its assets, the company is less efficient in making profit.
  • The TTM is -0.3%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ1.8%TTM-0.3%+2.1%
TTM-0.3%YOY-1.5%+1.2%
TTM-0.3%5Y-0.6%+0.4%
5Y-0.6%10Y-0.4%-0.2%
Compared to industry (Other)
PeriodCompanyIndustry (mean)+/- 
MRQ1.8%1.2%+0.6%
TTM-0.3%1.2%-1.5%
YOY-1.5%1.6%-3.1%
5Y-0.6%1.3%-1.9%
10Y-0.4%1.4%-1.8%
1.1.3. Return on Equity

Shows how efficient Biotest Aktiengesellschaft is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Biotest Aktiengesellschaft to the Other industry mean.
  • 5.9% Return on Equity means Biotest Aktiengesellschaft generated €0.06 for each €1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Biotest Aktiengesellschaft:

  • The MRQ is 5.9%. Using its investors money, the company is less efficient in making profit.
  • The TTM is -0.8%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ5.9%TTM-0.8%+6.8%
TTM-0.8%YOY-4.3%+3.5%
TTM-0.8%5Y-1.8%+1.0%
5Y-1.8%10Y-1.1%-0.7%
Compared to industry (Other)
PeriodCompanyIndustry (mean)+/- 
MRQ5.9%4.3%+1.6%
TTM-0.8%4.0%-4.8%
YOY-4.3%5.0%-9.3%
5Y-1.8%3.8%-5.6%
10Y-1.1%3.9%-5.0%
3rd Party Ad. No recommendation by Penke. PLUS is ad-free.

1.2. Operating Efficiency of Biotest Aktiengesellschaft.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Biotest Aktiengesellschaft is operating .

  • Measures how much profit Biotest Aktiengesellschaft makes for each €1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Biotest Aktiengesellschaft to the Other industry mean.
  • An Operating Margin of 0.0% means the company generated €0.00  for each €1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Biotest Aktiengesellschaft:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-0.2%+0.2%
5Y-0.2%10Y-270.6%+270.3%
Compared to industry (Other)
PeriodCompanyIndustry (mean)+/- 
MRQ-17.1%-17.1%
TTM-17.5%-17.5%
YOY-13.5%-13.5%
5Y-0.2%6.1%-6.3%
10Y-270.6%7.3%-277.9%
1.2.2. Operating Ratio

Measures how efficient Biotest Aktiengesellschaft is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Other industry mean).
  • An Operation Ratio of 1.52 means that the operating costs are €1.52 for each €1 in net sales.

Let's take a look of the Operating Ratio trends of Biotest Aktiengesellschaft:

  • The MRQ is 1.516. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.735. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.516TTM1.735-0.219
TTM1.735YOY1.928-0.193
TTM1.7355Y1.785-0.051
5Y1.78510Y1.400+0.385
Compared to industry (Other)
PeriodCompanyIndustry (mean)+/- 
MRQ1.5161.219+0.297
TTM1.7351.196+0.539
YOY1.9281.165+0.763
5Y1.7851.243+0.542
10Y1.4001.355+0.045
3rd Party Ad. No recommendation by Penke. PLUS is ad-free.

1.3. Liquidity of Biotest Aktiengesellschaft.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Biotest Aktiengesellschaft is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Other industry mean).
  • A Current Ratio of 5.05 means the company has €5.05 in assets for each €1 in short-term debts.

Let's take a look of the Current Ratio trends of Biotest Aktiengesellschaft:

  • The MRQ is 5.055. The company is very able to pay all its short-term debts. +2
  • The TTM is 4.741. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ5.055TTM4.741+0.314
TTM4.741YOY4.775-0.034
TTM4.7415Y4.597+0.144
5Y4.59710Y4.119+0.477
Compared to industry (Other)
PeriodCompanyIndustry (mean)+/- 
MRQ5.0551.538+3.517
TTM4.7411.538+3.203
YOY4.7751.499+3.276
5Y4.5971.482+3.115
10Y4.1191.480+2.639
1.3.2. Quick Ratio

Measures if Biotest Aktiengesellschaft is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Biotest Aktiengesellschaft to the Other industry mean.
  • A Quick Ratio of 1.32 means the company can pay off €1.32 for each €1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Biotest Aktiengesellschaft:

  • The MRQ is 1.318. The company is able to pay all its short-term debts with the most liquid assets. +1
  • The TTM is 1.143. The company is just able to pay all its short-term debts with the most liquid assets.
Trends
Current periodCompared to+/- 
MRQ1.318TTM1.143+0.176
TTM1.143YOY1.026+0.117
TTM1.1435Y1.111+0.032
5Y1.11110Y1.075+0.036
Compared to industry (Other)
PeriodCompanyIndustry (mean)+/- 
MRQ1.3180.625+0.693
TTM1.1430.601+0.542
YOY1.0260.620+0.406
5Y1.1110.620+0.491
10Y1.0750.602+0.473
3rd Party Ad. No recommendation by Penke. PLUS is ad-free.

1.4. Solvency of Biotest Aktiengesellschaft.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Biotest Aktiengesellschaft assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Biotest Aktiengesellschaft to Other industry mean.
  • A Debt to Asset Ratio of 0.69 means that Biotest Aktiengesellschaft assets are financed with 69.2% credit (debt) and the remaining percentage (100% - 69.2%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Biotest Aktiengesellschaft:

  • The MRQ is 0.692. The company is able to pay all its debts by selling its assets. +1
  • The TTM is 0.693. The company is able to pay all its debts by selling its assets. +1
Trends
Current periodCompared to+/- 
MRQ0.692TTM0.6930.000
TTM0.693YOY0.657+0.035
TTM0.6935Y0.623+0.069
5Y0.62310Y0.629-0.005
Compared to industry (Other)
PeriodCompanyIndustry (mean)+/- 
MRQ0.6920.527+0.165
TTM0.6930.530+0.163
YOY0.6570.558+0.099
5Y0.6230.566+0.057
10Y0.6290.575+0.054
1.4.2. Debt to Equity Ratio

Measures if Biotest Aktiengesellschaft is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Biotest Aktiengesellschaft to the Other industry mean.
  • A Debt to Equity ratio of 225.1% means that company has €2.25 debt for each €1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Biotest Aktiengesellschaft:

  • The MRQ is 2.251. The company is just not able to pay all its debts with equity.
  • The TTM is 2.255. The company is just not able to pay all its debts with equity.
Trends
Current periodCompared to+/- 
MRQ2.251TTM2.255-0.005
TTM2.255YOY1.922+0.333
TTM2.2555Y1.712+0.543
5Y1.71210Y1.739-0.027
Compared to industry (Other)
PeriodCompanyIndustry (mean)+/- 
MRQ2.2511.095+1.156
TTM2.2551.154+1.101
YOY1.9221.219+0.703
5Y1.7121.327+0.385
10Y1.7391.485+0.254
3rd Party Ad. No recommendation by Penke. PLUS is ad-free.

2. Market Valuation of Biotest Aktiengesellschaft

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every €1 in earnings Biotest Aktiengesellschaft generates.

  • Above 15 is considered overpriced but always compare Biotest Aktiengesellschaft to the Other industry mean.
  • A PE ratio of 18.54 means the investor is paying €18.54 for every €1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Biotest Aktiengesellschaft:

  • The EOD is 18.805. Based on the earnings, the company is fair priced.
  • The MRQ is 18.538. Based on the earnings, the company is fair priced.
  • The TTM is 34.092. Based on the earnings, the company is overpriced. -1
Trends
Current periodCompared to+/- 
EOD18.805MRQ18.538+0.267
MRQ18.538TTM34.092-15.554
TTM34.092YOY-41.539+75.631
TTM34.0925Y23.338+10.754
5Y23.33810Y18.265+5.073
Compared to industry (Other)
PeriodCompanyIndustry (mean)+/- 
EOD18.80511.822+6.983
MRQ18.53811.071+7.467
TTM34.09210.532+23.560
YOY-41.53911.512-53.051
5Y23.33812.436+10.902
10Y18.26512.585+5.680
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Biotest Aktiengesellschaft:

  • The EOD is -11.133. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -10.974. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -12.935. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-11.133MRQ-10.974-0.158
MRQ-10.974TTM-12.935+1.961
TTM-12.935YOY14.511-27.446
TTM-12.9355Y-4.043-8.892
5Y-4.04310Y-3.164-0.879
Compared to industry (Other)
PeriodCompanyIndustry (mean)+/- 
EOD-11.1336.667-17.800
MRQ-10.9746.303-17.277
TTM-12.9354.655-17.590
YOY14.5113.294+11.217
5Y-4.0432.859-6.902
10Y-3.1643.369-6.533
3rd Party Ad. No recommendation by Penke. PLUS is ad-free.
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Biotest Aktiengesellschaft is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Other industry mean).
  • A PB ratio of 4.41 means the investor is paying €4.41 for each €1 in book value.

Let's take a look of the Price to Book Ratio trends of Biotest Aktiengesellschaft:

  • The EOD is 4.471. Based on the equity, the company is fair priced.
  • The MRQ is 4.407. Based on the equity, the company is fair priced.
  • The TTM is 4.585. Based on the equity, the company is fair priced.
Trends
Current periodCompared to+/- 
EOD4.471MRQ4.407+0.064
MRQ4.407TTM4.585-0.177
TTM4.585YOY4.398+0.187
TTM4.5855Y2.874+1.711
5Y2.87410Y2.249+0.625
Compared to industry (Other)
PeriodCompanyIndustry (mean)+/- 
EOD4.4711.493+2.978
MRQ4.4071.218+3.189
TTM4.5851.258+3.327
YOY4.3981.532+2.866
5Y2.8741.426+1.448
10Y2.2491.518+0.731
2. Total Gains per Share
3rd Party Ad. No recommendation by Penke. PLUS is ad-free.

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Biotest Aktiengesellschaft compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--0.5660.094+505%-0.402+171%0.629-10%0.629-10%
Book Value Per Share--9.4399.094+4%9.643-2%8.570+10%6.707+41%
Current Ratio--5.0554.741+7%4.775+6%4.597+10%4.119+23%
Debt To Asset Ratio--0.6920.6930%0.657+5%0.623+11%0.629+10%
Debt To Equity Ratio--2.2512.2550%1.922+17%1.712+31%1.739+29%
Dividend Per Share----0%-0%-0%-0%
Eps--0.561-0.063+111%-0.411+173%-0.177+132%-0.139+125%
Free Cash Flow Per Share---0.948-0.926-2%0.192-593%-0.294-69%-0.294-69%
Free Cash Flow To Equity Per Share---0.948-0.926-2%0.192-593%-0.294-69%-0.294-69%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max---44.830--------
Intrinsic Value_10Y_min---37.663--------
Intrinsic Value_1Y_max---1.723--------
Intrinsic Value_1Y_min---1.691--------
Intrinsic Value_3Y_max---7.288--------
Intrinsic Value_3Y_min---6.915--------
Intrinsic Value_5Y_max---15.397--------
Intrinsic Value_5Y_min---14.109--------
Market Cap--1646172403.2001648150975.8000%1674861705.900-2%1127896302.700+46%882701454.287+86%
Net Profit Margin--0.141-0.038+127%-0.121+186%-0.062+144%2.666-95%
Operating Margin----0%-0%-0.0020%-2.7060%
Operating Ratio--1.5161.735-13%1.928-21%1.785-15%1.400+8%
Pb Ratio4.471+1%4.4074.585-4%4.398+0%2.874+53%2.249+96%
Pe Ratio18.805+1%18.53834.092-46%-41.539+324%23.338-21%18.265+1%
Price Per Share42.200+1%41.60041.6500%42.325-2%32.319+29%31.002+34%
Price To Free Cash Flow Ratio-11.133-1%-10.974-12.935+18%14.511-176%-4.043-63%-3.164-71%
Price To Total Gains Ratio74.550+1%73.490-14.387+120%-158.261+315%-115.411+257%-115.411+257%
Quick Ratio--1.3181.143+15%1.026+28%1.111+19%1.075+23%
Return On Assets--0.018-0.003+114%-0.015+180%-0.006+136%-0.004+123%
Return On Equity--0.059-0.008+114%-0.043+172%-0.018+131%-0.011+119%
Total Gains Per Share--0.5660.094+505%-0.402+171%0.629-10%0.629-10%
Usd Book Value--410625900.000395646575.000+4%419531040.000-2%463336022.222-11%443617460.000-7%
Usd Book Value Change Per Share--0.6220.103+505%-0.442+171%0.692-10%0.692-10%
Usd Book Value Per Share--10.3779.998+4%10.602-2%9.422+10%7.374+41%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps--0.617-0.069+111%-0.452+173%-0.195+132%-0.153+125%
Usd Free Cash Flow---41227500.000-40265525.000-2%8355440.000-593%-12594237.778-69%-30888360.000-25%
Usd Free Cash Flow Per Share---1.042-1.018-2%0.211-593%-0.324-69%-0.324-69%
Usd Free Cash Flow To Equity Per Share---1.042-1.018-2%0.211-593%-0.324-69%-0.324-69%
Usd Market Cap--1809801940.0781811977182.7950%1841342959.466-2%1240009195.188+46%970441978.843+86%
Usd Price Per Share46.395+1%45.73545.7900%46.532-2%35.532+29%34.083+34%
Usd Profit--24406680.000-2748500.000+111%-17892735.000+173%-7897356.667+132%-5057240.000+121%
Usd Revenue--173705200.000147924270.000+17%140420865.000+24%134994104.444+29%127927140.000+36%
Usd Total Gains Per Share--0.6220.103+505%-0.442+171%0.692-10%0.692-10%
 EOD+3 -3MRQTTM+23 -9YOY+17 -155Y+18 -1410Y+15 -17

3.2. Fundamental Score

Let's check the fundamental score of Biotest Aktiengesellschaft based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-1518.805
Price to Book Ratio (EOD)Between0-14.471
Net Profit Margin (MRQ)Greater than00.141
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than11.318
Current Ratio (MRQ)Greater than15.055
Debt to Asset Ratio (MRQ)Less than10.692
Debt to Equity Ratio (MRQ)Less than12.251
Return on Equity (MRQ)Greater than0.150.059
Return on Assets (MRQ)Greater than0.050.018
Total4/10 (40.0%)

3.3. Technical Score

Let's check the technical score of Biotest Aktiengesellschaft based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5055.155
Ma 20Greater thanMa 5041.880
Ma 50Greater thanMa 10042.100
Ma 100Greater thanMa 20042.018
OpenGreater thanClose42.000
Total3/5 (60.0%)



Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2022-06-302022-09-302022-12-312023-03-312023-06-30
EBITDA  -1,200-3,200-4,400-600-5,000-500-5,50037,80032,300



Latest Balance Sheet

Balance Sheet of 2023-06-30. Currency in EUR. All numbers in thousands.

Summary
Total Assets1,214,100
Total Liabilities840,600
Total Stockholder Equity373,500
 As reported
Total Liabilities 840,600
Total Stockholder Equity+ 373,500
Total Assets = 1,214,100

Assets

Total Assets1,214,100
Total Current Assets620,700
Long-term Assets620,700
Total Current Assets
Cash And Cash Equivalents 58,300
Short-term Investments 12,600
Net Receivables 149,300
Inventory 341,100
Other Current Assets 15,300
Total Current Assets  (as reported)620,700
Total Current Assets  (calculated)576,600
+/- 44,100
Long-term Assets
Long-term Assets Other 200
Long-term Assets  (as reported)593,400
Long-term Assets  (calculated)200
+/- 593,200

Liabilities & Shareholders' Equity

Total Current Liabilities122,800
Long-term Liabilities717,800
Total Stockholder Equity373,500
Total Current Liabilities
Accounts payable 54,500
Other Current Liabilities 18,300
Total Current Liabilities  (as reported)122,800
Total Current Liabilities  (calculated)72,800
+/- 50,000
Long-term Liabilities
Long-term Liabilities  (as reported)717,800
Long-term Liabilities  (calculated)0
+/- 717,800
Total Stockholder Equity
Retained Earnings 114,100
Total Stockholder Equity (as reported)373,500
Total Stockholder Equity (calculated)114,100
+/- 259,400
Other
Capital Stock39,600
Common Stock Shares Outstanding 39,571
Net Invested Capital 373,500
Net Working Capital 497,900



Balance Sheet

Currency in EUR. All numbers in thousands.

 Trend2023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-03-312017-12-312017-09-302017-06-302017-03-31
> Total Assets 
889,200
967,100
953,600
978,500
1,017,200
1,044,600
1,058,200
1,091,000
1,108,400
1,107,600
1,145,200
1,122,200
1,131,300
1,134,800
1,145,800
1,135,400
1,104,200
1,109,800
1,101,900
1,079,300
1,203,000
1,190,200
1,214,100
1,214,1001,190,2001,203,0001,079,3001,101,9001,109,8001,104,2001,135,4001,145,8001,134,8001,131,3001,122,2001,145,2001,107,6001,108,4001,091,0001,058,2001,044,6001,017,200978,500953,600967,100889,200
   > Total Current Assets 
392,000
396,500
368,800
449,700
487,600
476,100
488,600
508,500
522,800
525,600
563,900
542,200
556,300
560,600
570,500
556,600
522,200
523,900
522,000
497,500
619,400
597,400
620,700
620,700597,400619,400497,500522,000523,900522,200556,600570,500560,600556,300542,200563,900525,600522,800508,500488,600476,100487,600449,700368,800396,500392,000
       Cash And Cash Equivalents 
38,100
62,800
30,900
22,300
42,700
43,400
49,800
65,500
60,800
44,000
63,700
40,200
71,300
55,000
72,000
79,200
104,400
115,300
85,000
53,300
116,600
68,000
58,300
58,30068,000116,60053,30085,000115,300104,40079,20072,00055,00071,30040,20063,70044,00060,80065,50049,80043,40042,70022,30030,90062,80038,100
       Short-term Investments 
10,800
1,600
1,100
0
128,900
52,500
31,900
34,100
24,900
20,600
31,000
32,800
17,900
13,300
13,100
12,100
13,100
14,800
18,100
23,600
20,000
18,900
12,600
12,60018,90020,00023,60018,10014,80013,10012,10013,10013,30017,90032,80031,00020,60024,90034,10031,90052,500128,90001,1001,60010,800
       Net Receivables 
128,400
148,200
153,200
152,500
139,900
94,200
108,400
104,800
107,700
93,300
112,600
108,900
115,800
122,400
115,100
107,400
107,300
86,200
97,200
93,400
124,500
120,400
149,300
149,300120,400124,50093,40097,20086,200107,300107,400115,100122,400115,800108,900112,60093,300107,700104,800108,40094,200139,900152,500153,200148,200128,400
       Inventory 
167,200
170,700
169,900
146,900
165,100
236,000
247,000
257,300
280,100
312,400
304,300
306,900
290,100
301,800
303,100
298,100
244,600
255,800
263,200
268,700
293,800
327,600
341,100
341,100327,600293,800268,700263,200255,800244,600298,100303,100301,800290,100306,900304,300312,400280,100257,300247,000236,000165,100146,900169,900170,700167,200
       Other Current Assets 
47,500
13,200
13,700
127,400
11,000
12,900
10,100
6,900
1,400
9,600
8,400
9,700
1,200
18,700
13,400
12,100
3,100
18,000
15,400
23,600
3,100
20,400
15,300
15,30020,4003,10023,60015,40018,0003,10012,10013,40018,7001,2009,7008,4009,6001,4006,90010,10012,90011,000127,40013,70013,20047,500
   > Long-term Assets 
0
0
0
0
0
568,500
569,600
582,500
585,600
582,000
581,300
580,000
575,000
574,200
575,300
578,800
582,000
585,900
579,900
581,800
583,600
592,700
593,400
593,400592,700583,600581,800579,900585,900582,000578,800575,300574,200575,000580,000581,300582,000585,600582,500569,600568,50000000
       Property Plant Equipment 
436,700
455,700
475,500
298,700
487,900
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000000487,900298,700475,500455,700436,700
       Goodwill 
0
0
0
7,300
0
0
0
0
7,200
0
0
0
7,100
0
0
0
7,100
0
0
0
7,200
0
0
007,2000007,1000007,1000007,20000007,300000
       Long Term Investments 
5,800
55,500
47,100
2,300
2,700
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000002,7002,30047,10055,5005,800
       Intangible Assets 
24,800
24,100
24,300
4,000
16,200
0
0
0
6,600
0
0
0
6,900
0
0
0
4,100
0
0
0
9,200
0
0
009,2000004,1000006,9000006,60000016,2004,00024,30024,10024,800
       Long-term Assets Other 
0
0
0
0
0
100
569,600
7,700
100
5,600
3,600
3,700
100
300
100
100
400
500
300
500
100
200
200
2002001005003005004001001003001003,7003,6005,6001007,700569,60010000000
> Total Liabilities 
553,300
627,600
622,200
630,700
677,100
550,700
562,000
599,300
631,500
641,400
685,900
678,000
689,700
707,100
723,400
723,200
723,800
734,700
743,200
735,500
831,900
839,100
840,600
840,600839,100831,900735,500743,200734,700723,800723,200723,400707,100689,700678,000685,900641,400631,500599,300562,000550,700677,100630,700622,200627,600553,300
   > Total Current Liabilities 
118,500
135,100
136,500
251,200
385,000
107,800
415,600
101,100
115,000
123,100
113,800
103,300
105,600
121,100
111,100
103,800
106,400
114,900
122,200
109,600
130,200
129,500
122,800
122,800129,500130,200109,600122,200114,900106,400103,800111,100121,100105,600103,300113,800123,100115,000101,100415,600107,800385,000251,200136,500135,100118,500
       Short-term Debt 
350,500
414,300
412,400
406,400
471,300
0
0
0
3,300
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000003,300000471,300406,400412,400414,300350,500
       Short Long Term Debt 
350,500
414,300
412,400
406,400
471,300
0
0
0
3,300
0
0
0
3,500
0
0
0
1,600
0
0
0
4,800
0
0
004,8000001,6000003,5000003,300000471,300406,400412,400414,300350,500
       Accounts payable 
43,500
56,000
49,400
65,000
41,600
50,600
63,300
40,100
52,200
54,700
49,000
37,700
42,000
49,300
43,800
31,500
38,800
38,700
42,200
30,200
51,100
44,700
54,500
54,50044,70051,10030,20042,20038,70038,80031,50043,80049,30042,00037,70049,00054,70052,20040,10063,30050,60041,60065,00049,40056,00043,500
       Other Current Liabilities 
57,800
61,200
63,200
66,600
73,500
25,700
28,900
30,400
7,700
33,100
34,700
33,500
5,900
35,400
39,100
39,500
4,300
14,900
18,900
11,900
4,900
21,100
18,300
18,30021,1004,90011,90018,90014,9004,30039,50039,10035,4005,90033,50034,70033,1007,70030,40028,90025,70073,50066,60063,20061,20057,800
   > Long-term Liabilities 
0
0
0
0
0
442,900
146,400
498,200
516,500
518,300
572,100
574,700
584,100
586,000
612,300
619,400
617,400
619,800
621,000
625,900
701,700
709,600
717,800
717,800709,600701,700625,900621,000619,800617,400619,400612,300586,000584,100574,700572,100518,300516,500498,200146,400442,90000000
       Capital Lease Obligations 
0
0
0
0
0
0
0
0
26,700
0
0
0
27,400
0
0
0
26,800
0
0
0
29,000
0
0
0029,00000026,80000027,40000026,70000000000
       Long-term Liabilities Other 
0
0
0
0
0
100
200
200
300
100
0
0
-600
0
0
0
-1,900
0
0
100
-700
0
0
00-70010000-1,900000-6000010030020020010000000
> Total Stockholder Equity
335,700
339,300
331,200
347,600
339,900
493,900
496,200
491,700
476,900
466,200
459,300
444,200
441,600
427,700
422,400
412,200
380,400
375,100
358,700
343,800
371,100
351,100
373,500
373,500351,100371,100343,800358,700375,100380,400412,200422,400427,700441,600444,200459,300466,200476,900491,700496,200493,900339,900347,600331,200339,300335,700
   Common Stock
39,600
39,600
39,600
39,600
39,600
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000000039,60039,60039,60039,60039,600
   Retained Earnings 
76,300
45,700
71,800
58,300
80,500
52,900
234,800
232,300
217,500
206,800
199,900
184,800
182,200
168,300
163,000
152,800
121,000
115,700
99,300
84,400
111,700
91,700
114,100
114,10091,700111,70084,40099,300115,700121,000152,800163,000168,300182,200184,800199,900206,800217,500232,300234,80052,90080,50058,30071,80045,70076,300
   Capital Surplus 00000000000000000000000
   Treasury Stock00000000000000000000000
   Other Stockholders Equity 
0
34,200
0
29,900
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000000029,900034,2000



Balance Sheet

Currency in EUR. All numbers in thousands.




Cash Flow

Currency in EUR. All numbers in thousands.




Income Statement

Currency in EUR. All numbers in thousands.


Latest Income Statement (annual, 2022-12-31)

Gross Profit (+$)
totalRevenue516,100
Cost of Revenue-391,200
Gross Profit124,900124,900
 
Operating Income (+$)
Gross Profit124,900
Operating Expense-524,600
Operating Income-8,500-399,700
 
Operating Expense (+$)
Research Development50,500
Selling General Administrative80,700
Selling And Marketing Expenses0
Operating Expense524,600131,200
 
Net Interest Income (+$)
Interest Income800
Interest Expense-19,700
Other Finance Cost-3,900
Net Interest Income-22,800
 
Pretax Income (+$)
Operating Income-8,500
Net Interest Income-22,800
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-30,800-8,500
EBIT - interestExpense = -19,700
-31,700
-12,000
Interest Expense19,700
Earnings Before Interest and Taxes (EBIT)0-11,100
Earnings Before Interest and Taxes (EBITDA)24,700
 
After tax Income (+$)
Income Before Tax-30,800
Tax Provision-800
Net Income From Continuing Ops-31,700-31,600
Net Income-31,700
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses0
Total Other Income/Expenses Net022,800
 

Technical Analysis of Biotest Aktiengesellschaft
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Biotest Aktiengesellschaft. The general trend of Biotest Aktiengesellschaft is BULLISH with 57.1% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Biotest Aktiengesellschaft's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (57.1%) Bearish trend (-57.1%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Biotest Aktiengesellschaft.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is -1/(-1 +1).

  • Around resistance: The price is trading arround resistance levels. This can be considered as a potential exit level. -1

The bullish price targets are: 42.20 < 42.20 < 42.20.

The bearish price targets are: 41.20 > 41.20 > 41.20.

Tweet this
Biotest Aktiengesellschaft Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Biotest Aktiengesellschaft. The current mas is .

The long score for the Moving Averages is 11/14.
The longshort score for the Moving Averages is 8/(-14 +14).

  • MA 20 trending up: The MA 20 is trending up. +1
  • Close > MA 20: The price is above the MA 20. +1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 > MA 100: The MA 50 is higher than the MA 100. +1
  • MA 50 > MA 200: The MA 50 is higher than the MA 200. +1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close > MA 100: The price is above the MA 100. +1
  • MA 100 > MA 200: The MA 100 is higher than the MA 200. +1
  • MA 200 trending up: The MA 200 is trending up. +1
  • Close > MA 200: The price is above the MA 200. +1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Biotest Aktiengesellschaft Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Biotest Aktiengesellschaft. The current macd is 0.04304621.

The long score for the Moving Average Convergence/Divergence (MACD) is 4/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 4/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Biotest Aktiengesellschaft price going up in the near term. +2
  • MACD > 0: The MACD is above the zero line (centerline), it indicates a bullish signal for Biotest Aktiengesellschaft. This means that the short-term moving average is higher than the long-term moving average, signaling positive momentum and suggesting a higher likelihood of the Biotest Aktiengesellschaft price continuing to rise in the near future. It indicates that buyers are gaining control, and there is optimism in the market, leading to potential price increases. +1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Biotest Aktiengesellschaft Daily Moving Average Convergence/Divergence (MACD) ChartBiotest Aktiengesellschaft Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Biotest Aktiengesellschaft. The current adx is 14.75.

The long score for the Directional Movement Index (DMI) is 1/7.
The longshort score for the Directional Movement Index (DMI) is 1/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Biotest Aktiengesellschaft shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX < 25 && ADX trending down: The ADX is below 25 and indicates a weak or no trend. Also, the ADX is declining so there is no trend indication.
Biotest Aktiengesellschaft Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Biotest Aktiengesellschaft. The current sar is 41.26.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
Biotest Aktiengesellschaft Daily Parabolic SAR Chart
3rd Party Ad. No recommendation by Penke. PLUS is ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Biotest Aktiengesellschaft. The current rsi is 55.15. The current phase is Continuation in bull market.

The long score for the Relative Strength Index (RSI) is 4/13.
The longshort score for the Relative Strength Index (RSI) is 4/(-13 +13).

  • Continuation in bull market: Uptrend continues after a consolidation or pullback. Hold or add to existing positions.
  • Trending up: The RSI is trending up. +1
Biotest Aktiengesellschaft Daily Relative Strength Index (RSI) ChartBiotest Aktiengesellschaft Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Biotest Aktiengesellschaft. The current phase is Overbought in bull market.

The long score for the Stochastic Oscillator is 6/6.
The longshort score for the Stochastic Oscillator is 6/(-6 +6).

  • STOCH > 50: The STOCH %K is above 50. There are more buyers than sellers. +1
  • STOCH > 80: The STOCH %K is above 80 and overbought. +2
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Biotest Aktiengesellschaft price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
Biotest Aktiengesellschaft Daily Stochastic Oscillator ChartBiotest Aktiengesellschaft Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Biotest Aktiengesellschaft. The current cci is 78.16.

Biotest Aktiengesellschaft Daily Commodity Channel Index (CCI) ChartBiotest Aktiengesellschaft Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Biotest Aktiengesellschaft. The current cmo is 16.75.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
Biotest Aktiengesellschaft Daily Chande Momentum Oscillator (CMO) ChartBiotest Aktiengesellschaft Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Biotest Aktiengesellschaft. The current willr is 0.

The long score for the Williams %R is 1/1.
The longshort score for the Williams %R is 1/(-1 +1).

  • WILLR > -20: The Williams %R is above -20. This indicates that the price is in overbought territory, suggesting a potential price correction or trend reversal to the downside. +1
Biotest Aktiengesellschaft Daily Williams %R ChartBiotest Aktiengesellschaft Daily Williams %R Chart
3rd Party Ad. No recommendation by Penke. PLUS is ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Biotest Aktiengesellschaft.

Biotest Aktiengesellschaft Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Biotest Aktiengesellschaft. The current atr is 0.25231456.

Biotest Aktiengesellschaft Daily Average True Range (ATR) ChartBiotest Aktiengesellschaft Daily Average True Range (ATR) Chart
3rd Party Ad. No recommendation by Penke. PLUS is ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Biotest Aktiengesellschaft. The current obv is -49.

Biotest Aktiengesellschaft Daily On-Balance Volume (OBV) ChartBiotest Aktiengesellschaft Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Biotest Aktiengesellschaft. The current mfi is 60.02.

The long score for the Money Flow Index (MFI) is 1/2.
The longshort score for the Money Flow Index (MFI) is 1/(-2 +2).

  • MFI > 50: +1
Biotest Aktiengesellschaft Daily Money Flow Index (MFI) ChartBiotest Aktiengesellschaft Daily Money Flow Index (MFI) Chart
3rd Party Ad. No recommendation by Penke. PLUS is ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Biotest Aktiengesellschaft.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-07-13STOCH SHORT EXITThe %K line crosses above the %D line.
2023-07-14STOCH LONG EXITThe %K line crosses below the %D line.
2023-07-18MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2023-07-20DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-07-21STOCH LONG EXITThe %K line crosses below the %D line.
2023-07-24CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2023-07-25STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-07-27STOCH LONG EXITThe %K line crosses below the %D line.
2023-07-28STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-08-01STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-08-02MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2023-08-03STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-08-04MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-08-07CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2023-08-08STOCH LONG EXITThe %K line crosses below the %D line.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2023-08-09DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2023-08-10CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-08-11MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2023-08-16DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-08-17DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-08-18STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-08-21STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-08-24CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2023-08-29DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-08-30MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2023-08-31STOCH LONG EXITThe %K line crosses below the %D line.
2023-09-01MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-09-04STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-09-05STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-09-08STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2023-09-11STOCH SHORT EXITThe %K line crosses above the %D line.
2023-09-12STOCH LONG EXITThe %K line crosses below the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-09-14MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-09-15STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-09-18DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-09-19CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-09-20STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-09-21CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2023-09-22STOCH LONG EXITThe %K line crosses below the %D line.
2023-09-25STOCH SHORT EXITThe %K line crosses above the %D line.
2023-09-26STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-09-28STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-10-02STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-10-03STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-10-04BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2023-10-05STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-10-06CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-10-09CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-10-10CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-10-12MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-10-20SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2023-10-23CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2023-10-24STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-10-25CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-10-26STOCH LONG EXITThe %K line crosses below the %D line.
2023-10-27CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-10-30STOCH SHORT EXITThe %K line crosses above the %D line.
2023-10-31BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2023-11-01STOCH LONG EXITThe %K line crosses below the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2023-11-03BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2023-11-07MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2023-11-09CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2023-11-10MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2023-11-13STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-14STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-11-15STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-11-16STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-11-17STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-23DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-11-27STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-28STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside

6.3. Candlestick Patterns

Biotest Aktiengesellschaft Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Biotest Aktiengesellschaft based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5055.155
Ma 20Greater thanMa 5041.880
Ma 50Greater thanMa 10042.100
Ma 100Greater thanMa 20042.018
OpenGreater thanClose42.000
Total3/5 (60.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Biotest Aktiengesellschaft with someone you think should read this too:
  • Are you bullish or bearish on Biotest Aktiengesellschaft? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Biotest Aktiengesellschaft? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Biotest Aktiengesellschaft

I send you an email if I find something interesting about Biotest Aktiengesellschaft.


Comments

How you think about this?

Leave a comment
3rd Party Ad. No recommendation by Penke. PLUS is ad-free.

Stay informed about Biotest Aktiengesellschaft.

Receive notifications about Biotest Aktiengesellschaft in your mailbox!